• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

自然主义迷幻药使用中的种族差异——使用动机、与医疗保健提供者的沟通及结果

Racial Differences in Naturalistic Psychedelic Use - Motivations for Use, Communication with Health Care Providers, and Outcomes.

作者信息

Glynos Nicolas G, Reid Mallet R, Aday Jacob S, Kruger Daniel J, Boehnke Kevin F, Lake Stephanie, Lucas Philippe

机构信息

Anesthesiology Department, University of Michigan Medical School, Ann Arbor, MI, USA.

Chronic Pain and Fatigue Research Center, University of Michigan Medical School, Ann Arbor, MI, USA.

出版信息

J Psychoactive Drugs. 2025 Apr 22:1-12. doi: 10.1080/02791072.2025.2491381.

DOI:10.1080/02791072.2025.2491381
PMID:40260901
Abstract

People of Color have been under-included in psychedelic-assisted therapy (PAT) research. Researchers have argued that systemic issues resulting in harms to communities of color like the War on Drugs and recurrent exposure to discrimination in healthcare settings may reduce their willingness to engage in PAT research. However, there are no empirical data regarding People of Color's trust or willingness in using psychedelics with support of trained healthcare providers. Therefore, we analyzed data from a large-scale survey of people using psychedelics to explore interactions between People of Color and healthcare providers in North America. The sample included 3,547 White people, 448 People of Color, and 377 Multiracial people. A lower proportion of People of Color consumed psychedelics with the support of a trained provider but an equal proportion had disclosed psychedelic use to primary care providers. Further, People of Color were equally motivated to use psychedelics with a trained healthcare provider, used psychedelics to treat similar issues, and similarly reported psychedelics as effective with other groups. Our findings suggest that lack of trust may not fully explain the underrepresentation of People of Color in PAT research, and future studies should investigate other barriers to People of Color's inclusion in PAT research.

摘要

有色人种在迷幻剂辅助治疗(PAT)研究中的参与度一直不足。研究人员认为,诸如毒品战争以及在医疗环境中反复遭受歧视等系统性问题对有色人种社区造成了伤害,这可能会降低他们参与PAT研究的意愿。然而,目前尚无关于有色人种在受过培训的医疗服务提供者支持下使用迷幻剂的信任度或意愿的实证数据。因此,我们分析了一项针对使用迷幻剂人群的大规模调查数据,以探讨北美有色人种与医疗服务提供者之间的互动情况。样本包括3547名白人、448名有色人种和377名多种族人士。在受过培训的提供者支持下使用迷幻剂的有色人种比例较低,但向初级保健提供者披露迷幻剂使用情况的比例相同。此外,有色人种同样有动力在受过培训的医疗服务提供者的支持下使用迷幻剂,使用迷幻剂治疗类似问题,并且同样报告迷幻剂对其他群体有效。我们的研究结果表明,缺乏信任可能无法完全解释有色人种在PAT研究中代表性不足的问题,未来的研究应该调查有色人种参与PAT研究的其他障碍。

相似文献

1
Racial Differences in Naturalistic Psychedelic Use - Motivations for Use, Communication with Health Care Providers, and Outcomes.自然主义迷幻药使用中的种族差异——使用动机、与医疗保健提供者的沟通及结果
J Psychoactive Drugs. 2025 Apr 22:1-12. doi: 10.1080/02791072.2025.2491381.
2
Exploring psychedelic use in athletes and their attitudes toward psilocybin-assisted therapy in concussion recovery.探索运动员使用迷幻剂的情况及其对裸盖菇素辅助治疗脑震荡恢复的态度。
Ther Adv Psychopharmacol. 2024 Aug 7;14:20451253241264812. doi: 10.1177/20451253241264812. eCollection 2024.
3
Slouching towards engagement: interactions between people using psychedelics naturalistically and their healthcare providers.迈向参与的萎靡姿态:自然使用迷幻剂的人与他们的医疗服务提供者之间的互动。
Front Psychiatry. 2023 Aug 4;14:1224551. doi: 10.3389/fpsyt.2023.1224551. eCollection 2023.
4
Naturalistic Psychedelic Use: A World Apart from Clinical Care.自然主义的迷幻药使用:与临床治疗截然不同。
J Psychoactive Drugs. 2023 Sep-Oct;55(4):379-388. doi: 10.1080/02791072.2022.2108356. Epub 2022 Aug 11.
5
Psychedelic-assisted therapy for treating anxiety, depression, and existential distress in people with life-threatening diseases.致幻剂辅助治疗对患有危及生命疾病的人群的焦虑、抑郁和存在性困扰的治疗作用。
Cochrane Database Syst Rev. 2024 Sep 12;9(9):CD015383. doi: 10.1002/14651858.CD015383.pub2.
6
People of color in North America report improvements in racial trauma and mental health symptoms following psychedelic experiences.北美有色人种报告称,在经历迷幻体验后,种族创伤和心理健康症状有所改善。
Drugs (Abingdon Engl). 2021;28(3):215-226. doi: 10.1080/09687637.2020.1854688. Epub 2020 Dec 10.
7
Going Underground: Demographics, Services, and Best Practices Endorsed by Practitioners Providing Support for Naturalistic Psychedelic Use.转入地下:为自然主义迷幻药使用提供支持的从业者认可的人口统计学、服务及最佳实践
J Psychoactive Drugs. 2024 Sep 19:1-11. doi: 10.1080/02791072.2024.2405685.
8
Ethnoracial inclusion in clinical trials of psychedelics: a systematic review.迷幻药临床试验中的种族纳入情况:一项系统综述。
EClinicalMedicine. 2024 Jul 3;74:102711. doi: 10.1016/j.eclinm.2024.102711. eCollection 2024 Aug.
9
An Assessment of Psychedelic Knowledge Among People Using Psychedelics Naturalistically.对自然使用迷幻剂人群的迷幻剂知识评估。
J Psychoactive Drugs. 2023 Sep-Oct;55(4):420-424. doi: 10.1080/02791072.2022.2142709. Epub 2022 Nov 3.
10
Moving psychedelic-assisted therapies from promising research into routine clinical practice: Lessons from the field of implementation science.将迷幻辅助疗法从有前途的研究推向常规临床实践:来自实施科学领域的经验教训。
Transl Behav Med. 2024 Nov 25;14(12):744-752. doi: 10.1093/tbm/ibae053.